AGEN vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

AGEN

45.7
AI Score
VS
CBIO Wins

CBIO

58.4
AI Score

Investment Advisor Scores

AGEN

46score
Recommendation
HOLD

CBIO

58score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AGEN CBIO Winner
Revenue 68.25M 1.04M AGEN
Net Income 38.64M -48.12M AGEN
Net Margin 56.6% -4631.4% AGEN
Operating Income 26.35M -51.09M AGEN
ROE -19.4% -29.5% AGEN
ROA 22.4% -26.3% AGEN
Total Assets 172.69M 182.76M CBIO
Cash 18.74M 171.59M CBIO
Current Ratio 0.34 9.66 CBIO

Relative Price Performance (Last 90 Days)

AGEN 1M: +3.3% · 3M: +145.2% CBIO 1M: -22.8% · 3M: -15.6%

Current Technical Phase

AGEN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (25.0% over 20 days), RSI 53

RSI (14): 52.5 · Price: $8.36

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 35.6 · Price: $14.32

Fundamentals Snapshot

Metric AGEN CBIO
Market Cap — —
Forward P/E -76.0 -5.4
Trailing P/E 2.8 —
Revenue (TTM) — —
Revenue Growth 0.3% 0.0%
Gross Margin 1.1% 1.0%
Operating Margin 0.3% -14.3%
EPS 2.99 -0.14
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CBIO is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.